Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

Go back to Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
(NASDAQ: LEXX) Delayed: 0.56 -0.01 (1.75%)
Previous Close $0.57    52 Week High
Open $0.57    52 Week Low
Day High $0.60    P/E N/A 
Day Low $0.56    EPS
Volume 48,948